Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 重庆太极实业(集团)股份有限公司主要从事中成药、西药、保健用品加工、销售,医疗包装制品加工,医疗器械销售等,是重庆市重点扶持的30家优势扩张企业之一.现拥有两家上市公司:重庆桐君阁股份有限公司和西南药业股份有限公司,下属独立法人企业46. 公司现有中西药品种1,000多个,全国独家生产的中西药品种30多个,列入二○○○版《中国药典》的品种122个,列入国家基本药物目录的品种214个,获专利保护的品种20多个,获得国家中药保护的品种20个。
Main Business 中成药、西药、保健用品、医疗包装制品、医疗器械产销及原材料、中药材、药用包装的进出口业务。
Legal Representative 李阳春
Top Executives
董事长：李阳春
董事：李阳春,赖波,孟庆鑫,王刊,杨秉华,俞敏,赵东吉,陈通,程学仁
独立董事：吴宪,何洪涛,熊少希,田卫星,沈翎
Top 5 Shareholder
Shareholder name Nature Holding Date
太极集团有限公司流通A股27.62%31/03/2024
重庆市涪陵国有资产投资经营集团有限公司流通A股7.92%31/03/2024
重庆市涪陵区希兰生物科技有限公司流通A股2.14%31/03/2024
中国工商银行股份有限公司－中欧医疗健康混合型证券投资基金流通A股1.69%31/03/2024
香港中央结算有限公司流通A股1.55%31/03/2024
Company Secretary 蒋茜
Solicitors 北京市康达律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0023-89886129
Fax No 023-89887399
Website www.taiji.com
Email tjzq@taiji.com
Company Address
Register: 重庆市涪陵区太极大道1号
Office: 重庆市渝北区恒山东路18号
Listing Date 18/11/1997
Shares Capital
Shares Capital: 556,890,744
Total A Share: 556,890,744
Listed A Share: 556,890,744
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.480
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 6.504
Market Capitalization(RMB) 21.552B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.